Clinical Trial Update: Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating antiandrogen therapy (abiraterone acetate) with or without neutron radiation therapy in castration-sensitive/prostate cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Prostate Cancer
• Stage Iva Prostate Cancer
• Stage Ivb Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Washington | Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Status: TERMINATED | Results posted: 2023-10-26